Incorporating patient-reported outcomes in a phase I clinical trial

被引：0
|
作者：
Qin, Rui [1 ]
Dueck, Amylou C. [2 ]
Satele, Daniel [1 ]
Molina, Julian [1 ]
Erlichman, Charles [1 ]
Basch, Ethan [3 ]
Sloan, Jeff [4 ]
机构：
[1] Mayo Clin, Rochester, MN USA
[2] Mayo Clin, Scottsdale, AZ USA
[3] Univ N Carolina, Chapel Hill, NC USA
[4] Mayo Clin, Rochester, MN USA
来源：
QUALITY OF LIFE RESEARCH | 2013年 / 22卷
关键词：
D O I：
暂无
中图分类号：
R19 [保健组织与事业（卫生事业管理）];
学科分类号：
摘要：
1088
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Isotonic Phase I Cancer Clinical Trial Design Utilizing Patient-Reported Outcomes
    Wages, Nolan A.
    Lin, Ruitao
    STATISTICS IN BIOPHARMACEUTICAL RESEARCH, 2025, 17 (01): : 36 - 45
  • [2] Incorporating Patient-Reported Outcomes in Periodontal Clinical Trials
    McGuire, Michael K.
    Scheyer, E. Todd
    Gwaltney, Chad
    JOURNAL OF PERIODONTOLOGY, 2014, 85 (10) : 1313 - 1319
  • [3] Using Patient-Reported Outcomes to Describe the Patient Experience on Phase I Clinical Trials
    Sedhom, Ramy
    Ferrell, Betty
    Ruel, Nora
    Koczywas, Marianna
    Chung, Vincent
    Smith, Thomas J.
    JNCI CANCER SPECTRUM, 2020, 4 (06)
  • [4] Reporting of patient-reported outcomes in clinical trial publications
    Sjostedt, Philip
    Busch, Cindy
    Coolbaugh, Nicole
    Martin, Susan
    CURRENT MEDICAL RESEARCH AND OPINION, 2019, 35 : 23 - 23
  • [5] Guidelines for Patient-Reported Outcomes in Clinical Trial Protocols
    Mehran, Roxana
    Baber, Usman
    Dangas, George
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2018, 319 (05): : 450 - 451
  • [6] Patient-Reported Outcomes for Tolerability Assessment in Phase I Cancer Clinical Trials
    Basch, Ethan
    Yap, Christina
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2021, 113 (08): : 943 - 944
  • [7] The Patient Knows Best: Incorporating Patient-Reported Outcomes Into Routine Clinical Care
    Nipp, Ryan
    Temel, Jennifer
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2017, 109 (09):
  • [8] Incorporating Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) into Dose Review in a Phase I Clinical Trial
    Mead-Harvey, Carolyn
    Noble, Brie N.
    Yee, Claire
    Mazza, Gina L.
    Langlais, Blake
    Patel, Sheetal
    Trask, Peter
    Rogak, Lauren
    Basch, Ethan
    Dueck, Amylou C.
    Thanarajasingam, Gita
    BLOOD, 2024, 144 : 2299 - 2300
  • [9] Incorporating patient-reported outcomes in dose-finding clinical trials
    Lee, Shing M.
    Lu, Xiaoqi
    Cheng, Bin
    STATISTICS IN MEDICINE, 2020, 39 (03) : 310 - 325
  • [10] Low Concordance of Patient-Reported Outcomes With Clinical and Clinical Trial Documentation
    Fares, Charlene M.
    Williamson, Timothy J.
    Theisen, Matthew K.
    Cummings, Amy
    Bornazyan, Krikor
    Carroll, James
    Spiegel, Marshall L.
    Stanton, Annette L.
    Garon, Edward B.
    JCO CLINICAL CANCER INFORMATICS, 2018, 2 : 1 - 12
12345